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The incidence of severe Haemophilus influenza infections, 
such as sepsis and meningitis, has declined substantially 
since the introduction of the H. influenzae serotype b vaccine. 
However, the H. influenzae type b vaccine fails to protect 
against nontypeable H. influenzae strains, which have be-
come increasingly frequent causes of invasive disease, 
especially among children and the elderly. We summarize 
recent literature supporting the emergence of invasive non-
typeable H. influenzae and describe mechanisms that may 
explain its increasing prevalence over the past 2 decades.
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SYNOPSIS
Haemophilus influenzae is an extracellular bacterium that commonly colonizes the upper respiratory tract 
of healthy humans, who are the bacterium’s only known 
natural reservoir. The H. influenzae species is subdivided 
into 7 groups, including 6 that express distinct serotypes of 
polysaccharide capsule (a–f) and 1 unencapsulated group 
termed nontypeable H. influenzae (NTHi). NTHi is most 
frequently associated with mild inflammatory diseases of 
the human mucosa, including otitis media (OM), sinusitis, 
and exacerbations of chronic obstructive pulmonary dis-
ease (COPD), but it can also cause invasive disease (1). The 
incidence of invasive NTHi (usually defined as isolation of 
NTHi from a normally sterile site) has increased substan-
tially since the introduction of the H. influenzae serotype b 
(Hib) vaccination in the early 1990s and of the Streptococ-
cus pneumoniae polysaccharide conjugate vaccine (PCV) 
in the early 2000s (2–5), but factors contributing to NTHi 
are poorly understood. We summarize data supporting the 
emergence of NTHi as an increasingly prominent cause of 
invasive bacterial disease and propose 4 factors that may be 
driving its rising prevalence worldwide.
Methods
We first summarized nationwide surveillance of invasive 
NTHi disease recorded by the Netherlands Reference Lab-
oratory for Bacterial Meningitis (6). Next, on November 
12, 2014, we systematically searched the US National Li-
brary of Medicine’s PubMed database (http://www.ncbi.
nlm.nih.gov/pubmed/) by using the search terms “inva-
sive nontypeable Haemophilus influenzae” and “invasive 
non-typeable Haemophilus influenzae.” We reviewed all 
papers published during 2000–2014 and summarized all 
surveillance studies meeting the following criteria: 1) writ-
ten in English; 2) recording invasive H. influenzae cases 
occurring during the post-Hib vaccine era; 3) spanning >4 
years; and 4) discriminating among serotype b, non–se-
rotype b, and NTHi strains (Table; online Technical Ap-
pendix, http://wwwnc.cdc.gov/EID/article/21/10/15-0004-
Techapp.pdf). Finally, we described mechanisms that may 
explain increased prevalence of invasive NTHi infections 
over the past 2 decades.
NTHi as Emerging Pathogen Causing Invasive  
Disease in the Netherlands
Until the mid-1990s, H. influenzae serotype b (Hib) was 
a predominant cause of invasive disease (e.g., pneumonia, 
sepsis, and meningitis), especially in children. In 1992, a 
total of 294 (93%) cases with H. influenzae isolates that 
caused sepsis or meningitis in the Netherlands were attrib-
uted to Hib alone. The introduction of an effective vaccine 
in 1993 drastically decreased the incidence of serotype b 
infections, which, by 1997, represented only 19 (22%) cas-
es with invasive Haemophilus isolates (6). However, with 
the near-elimination of invasive disease caused by Hib, the 
number of recorded invasive NTHi cases increased almost 
6-fold during the past 2 decades, from 20 in 1992 to 115 
in 2013 (Figure 1). Most (95%) of these NTHi isolates 
were collected from blood (6). NTHi invasion was detected 
mainly among persons >50 years of age (80%); Hib was 
found more often in children <5 years of age, who repre-
sented 45% of cases, compared with 38% for those >50 
years of age (6). As with the increased number of invasive 
NTHi cases, a notable increase in the prevalence of non–
serotype b encapsulated H. influenzae strains was also ob-
served in the Netherlands (Figure 2), although the number 
of such cases remains small (6).
NTHi as Emerging Pathogen Causing Invasive  
Disease Worldwide
Emergence of NTHi as a cause of invasive disease 
was reported in studies worldwide and was consistently 
the most prevalent H. influenzae that caused invasive dis-
ease (Table). In contrast, Hib cases represented <20% of 
invasive disease. Seven studies showed a clear increase 
in absolute numbers of invasive NTHi cases or increased 
incidence rates of invasive NTHi during the study period 
(online Technical Appendix references 1,7,8,11,15–17); 
4 studies showed no increase (online Technical Appen-
dix references 2,3,5,6). Large year-to-year differences in 
overall H. influenzae incidence reported by Laupland et al. 
make it difficult to interpret whether an increase in inva-
sive NTHi incidence occurred (online Technical Appen-
dix reference 6). Furthermore, a relatively low number of 
patients (n = 122) over an extended collection period of 
7 years complicates the year-to-year analysis in the study 
by Tsang et al. (online Technical Appendix reference 2). 
However, that study showed a significantly higher mean 
number of NTHi infections during 2004–2006 (12.7 ± 2.5), 
compared with the mean number during 2000–2003 (5.0 
± 2.6). Bamberger et al. observed no difference in the in-
cidence of invasive NTHi, perhaps explained by the study 
population, which consisted of children <15 years of age 
(online Technical Appendix reference 5). Globally, the av-
erage incidence of invasive NTHi is ≈1/100,000 population 
(4,7,8), a rate similar to that of the Netherlands (9).
Whereas Hib predominantly causes bacterial meningitis 
in healthy children <5 years of age, most invasive NTHi dis-
ease is found in very young children (<20 weeks of age) and 
the elderly (>65 years). In these populations, NTHi devel-
ops as pneumonia or bacteremia without apparent focus of 
infection (online Technical Appendix references 3,6,16,17). 
These findings contrast with the widely held view that NTHi 
infections are mild or asymptomatic. The potential severity 
of invasive NTHi is illustrated by case fatality rates of 10%–
20% (online Technical Appendix references 3,6,16), similar 
to case fatality rates for S. pneumoniae (10).
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Emergence of Capsulated, Non–Serotype b  
Haemophilus influenzae Strains
In addition to the increased incidence of NTHi infections, an 
increased number of invasive infections caused by encap-
sulated non–serotype b H. influenzae strains, especially Hie 
and Hif, has been observed in the Netherlands during the 
past 2 decades (Figure 2). This trend has been confirmed in 
multiple independent studies (online Technical Appendix 
references 3,11,17), although the increases are not as large 
as those observed for NTHi. In Europe, the incidence of 
non–serotype b H. influenzae capsulated strains was 690 
(9%) of 7,992 isolates; 500 (72.5%) of the 690 isolates 
were Hif, and 143 (20.7%) were Hie (online Technical Ap-
pendix reference 3). This distribution of non–serotype b H. 
influenzae encapsulated serotypes causing invasive disease 
was similar in other parts of the world, except for specific 
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Table. Invasive Haemophilus influenzae cases worldwide since introduction of serotype b vaccine* 
Location 
Period of 
strain 
collection 
Surveillance 
method 
Typing 
method 
Changes in 
NTHi cases or 
incidence† 
Serotyped 
Hi isolates, 
no. 
Serotype 
b 
isolates, % 
Non–
serotype b 
isolates, % 
NTHi 
isolates, 
% Ref 
Canada 1989–2007 Active, 
prospective 
surveillance 
SA Increased 
incidence 
1,455 20 17 62 (1) 
Canada 2000–2006 Nationwide 
surveillance 
SA+PCR No change 122 4 39 57 (2) 
Europe 1996–2006 European 
Union Invasive 
Bacterial 
Infection 
Surveillance 
SA or PCR No change 7,992 35 9 56 (3) 
Germany 2001–2004 Nationwide 
surveillance 
Not 
reported 
NA 147 40 14 46 (4) 
Israel‡ 2003–2012 Nationwide 
prospective 
surveillance 
SA No change 389 26 11 62 (5) 
Multiple§ 2000–2008 Active 
population-
based 
surveillance 
Not 
reported 
No change 398 6 17 77 (6) 
Portugal 2002–2010 Laboratory-
based passive 
surveillance 
PCR Increased 
cases 
144 13 10 77 (7) 
Slovenia 2000–2008 National 
surveillance 
PCR Increased 
incidence 
108¶ 13 2 85 (8) 
Spain 2004–2009 Nationwide 
surveillance 
PCR NA 307 5 8 87 (9) 
Spain 2008–2013 Laboratory-
based study 
SA NA 70 1 14 85 (10) 
Sweden 1997–2009 Retrospective 
laboratory-
based study 
PCR Increased 
cases or 
incidence 
268# 11 18 71 (11) 
Taiwan 1999–2002 National 
surveillance 
SA NA 10 20 0 80 (12) 
USA, 
Alaska 
1991–1996 Active 
surveillance 
SA NA 40 14 31 54 (13) 
USA, 
Arkansas 
1993–2001 Retrospective 
laboratory-
based study 
SA NA 33 3 6 91 (14) 
USA, Utah 1998–2008 Passive 
surveillance 
SA Increased 
cases or 
incidence 
101 9 49 43 (15) 
USA, 
Illinois 
1996–2004 Passive 
surveillance 
SA Increased 
incidence 
522 15 31 54 (16) 
USA 1999–2008 Active 
surveillance 
SA Increased 
incidence 
4190 4 26 70 (17,18) 
*Hi, Haemophilus influenzae; NA, not applicable due to limited sample size (<100 isolates) or lack of year-to-year data; NTHi, nontypeable Haemophilus 
influenzae; Ref, reference (see online Technical Appendix, http://wwwnc.cdc.gov/EID/article/21/10/15-0004-Techapp.pdf); SA, slide agglutination; 
SA+PCR, slide agglutination positive isolates confirmed by PCR. 
†Increased cases = increase in number of NTHi cases in patients >1 years of age; Increased incidence = increase in NTHi incidence rate in patients >1 
year of age; No change = no difference in number or incidence rate of NTHi cases. 
‡Pediatric cases (<15 years of age) only. 
§Australia, Canada, and Denmark. 
¶PCR-typed isolates from post-Hib vaccination era only. 
#PCR-typed isolates only. 
 
SYNOPSIS
ethnic groups where Hia is most prevalent (11–13). The 
epidemiology and clinical manifestations of invasive Hie 
and Hif strains are similar to that of NTHi and mostly occur 
as pneumonia or bacteremia in the elderly (14). In contrast, 
invasive Hia infections are more similar to Hib infections 
than to NTHi infections. Hia infections occurred mainly in 
young children and frequently as meningitis (12,13). The 
apparent similarity between Hia and Hib might be attribut-
ed to similarities in capsule structure; both contain a neutral 
sugar, an alcohol (ribitol), and a phosphodiester (15).
Possible Explanations for Emergence of 
Nontypeable Haemophilus influenzae
Although numbers of NTHi cases are increasing, underly-
ing mechanisms for the increase are yet to be determined. 
We offer 4 possible explanations for the emergence of 
NTHi as a pathogen causing invasive disease.
1) Vaccine-Mediated Strain Replacement
The success of the Hib vaccine and PCV is attributed to 
the strong immunogenic properties of polysaccharide con-
jugate formulations. However, protection against H. in-
fluenzae is limited to serotype b, and the possibility exists 
that another disease, caused by other H. influenzae strains 
against which vaccines offer no protection, may replace 
Hib. In fact, already in 1997, Marc Lipsitch anticipated the 
possibility of strain replacement with the introduction of 
the Hib vaccine (16). The significance of strain replace-
ment remains controversial: some clinical studies highlight 
its potential danger (2,4); others fail to observe it alto-
gether (8,17). Besides the introduction of the Hib vaccina-
tion, introduction of the PCV has also been proposed as 
contributing to H. influenzae strain replacement. Multiple 
studies show substantial increases in NTHi nasopharyngeal 
colonization (3,5) and in percentage of OM cases caused by 
NTHi in PCV-vaccinated persons (18–20). This increased 
nasopharyngeal carriage of NTHi in PCV-vaccinated chil-
dren might increase transmission to groups susceptible 
to invasive NTHi disease, such as the elderly, and might 
thereby contribute to the emergence of invasive NTHi dis-
ease. Strain replacement during colonization of persons 
>65 years of age appears to lack investigation, possibly be-
cause of the relatively low percentage of nasopharyngeal 
carriage in this age group. However, NTHi carriage rates 
in parents of PCV-vaccinated children increased from 23% 
prevaccination to 40% postvaccination (5), indicating that 
carriage of NTHi has increased in healthy adults, possibly 
because of increased transmission from PCV-vaccinated 
children. Increased NTHi carriage might contribute to the 
increased number of invasive NTHi disease cases recorded 
during the past 20 years.
2) Improved Bacterial Detection and Serotyping
Whether the emergence of NTHi as a cause of invasive 
disease indicates an actual increase in the number of cases 
or results from improved detection and serotyping is dif-
ficult to assess. Bacterial culture is the gold standard for 
H. influenzae detection. However, a major disadvantage of 
culture is that multiple days are needed to isolate bacte-
ria and confirm culture identity. Therefore, rapid and more 
sensitive real-time PCR (rtPCR) assays have been devel-
oped to shorten the time needed for identification. Several 
rtPCR assays that target different H. influenzae genes have 
been developed and are more sensitive for detecting the 
hpd gene than for detecting genes ompP2 or bexA (detec-
tion of capsulated H. influenzae strains only) (21). Despite 
evidence that rtPCR-based assays provide improved detec-
tion of H. influenzae, all studies we summarize use bacte-
rial culture as the detection method (Table).
Slide agglutination is the gold standard for serotyp-
ing H. influenzae in most laboratories, although this tech-
nique is prone to misinterpretation because of nonspecific 
agglutination, cross-reactions, or autoagglutination. The 
transition from slide-agglutination to PCR-based methods 
that detect capsule locus genes, such as bexA or bexB, has 
substantially improved the accuracy of serotyping results. 
For instance, Kastrin et al. recently showed that 80 isolates 
originally serotyped as NTHi were detected as unencapsu-
lated by PCR, but 12 (11% of total isolates) of 28 isolates 
reported as capsulated by slide agglutination were shown 
by PCR to harbor no functional capsule genes (7). On the 
basis of PCR results, 5%–20% of strains typed by slide 
agglutination were mistyped as encapsulated (7,22,23). 
Although PCR detection methods apparently detect more 
invasive NTHi isolates than does slide agglutination, the 
increased detection by PCR does not explain the year-to-
year increase in number of invasive NTHi cases (Table) 
because, within each study, similar typing techniques were 
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Figure 1. Number of recorded nontypeable Haemophilus 
influenzae (NTHi) isolates from blood or cerebrospinal fluid in the 
Netherlands, by year, 1992–2013. Adapted from (6).
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used throughout the study period. However, the number of 
invasive NTHi cases likely is underrepresented in studies 
that use slide agglutination for detection.
3) Increased Virulence of NTHi Strains
Increased bacterial virulence as a consequence of the ac-
quisition of novel virulence factors might also contribute 
to invasive NTHi disease. The natural genetic competence 
of NTHi enables the exchange of large pieces of DNA be-
tween strains at a high frequency (24), a process that sup-
ports acquisition of novel virulence factors.
Because invasive infection and death of host do not 
enhance transmissibility of virulent NTHi, the evolutionary 
basis for these genetic changes may lie in fitness advan-
tages during nasopharyngeal colonization, a theory sup-
ported by recent studies. For instance, we have shown that 
NTHi isolates collected from middle ear fluid of children 
with OM exhibited increased resistance to complement-
mediated killing compared with colonizing NTHi isolates 
from the nasopharynx (25), but we found that colonizing 
and OM-causing NTHi strains with a similar multilocus 
sequence type collected from the same patient showed no 
difference in complement resistance (26). This similarity 
in complement resistance for NTHi strains with a similar 
multilocus sequence type indicates that NTHi strains had 
already acquired mechanisms that increased resistance to 
complement-mediated killing during colonization and re-
tained them during translocation to the middle ear cavity. 
These observations were corroborated by a later study that 
showed that most of the phase-variable genes known to 
modulate resistance to complement-mediated killing were 
regulated similarly for colonizing and OM-causing NTHi 
strains within the same patient (27).
Limited data are available on the mechanisms that un-
derlie increased NTHi virulence in patients with invasive 
disease. Recently, Bajanca-Lavado et al. showed that an 
NTHi strain that caused endocarditis appeared highly viru-
lent because of the expression of a second copy of the IgA 
protease gene (igaB) combined with a strong resistance to 
complement-mediated killing (28). We have shown that 
NTHi strains collected from patients with invasive disease 
more frequently incorporate galactose to heptose III in the 
lipooligosaccharide; this modification decreases binding of 
IgM and thereby increases resistance to complement-me-
diated killing (29). A study by Hällstrom et al. showed a 
correlation between complement resistance and disease se-
verity but no difference in complement resistance between 
invasive and colonizing NTHi strains (30). This lack of 
difference in complement resistance between invasive and 
colonizing NTHi strains might be explained by the large 
proportion (41%) of patients with immune deficiencies in 
the invasive group, therefore potentially reducing the im-
munologic pressure for NTHi strains to maintain comple-
ment resistance in the bloodstream.
That the type b capsule protects H. influenzae from the 
bactericidal activity of the complement system and that this 
protection contributes to its invasive character are gener-
ally accepted ideas. Zwahlen et al. reported that capsule 
transformants showed dramatic differences in virulence 
(31). Although all capsule types were able to colonize the 
nasopharynx of rats, bacteremia was detected only in ani-
mals challenged with serotypes a and b and with a single 
animal serotype, f. The highest bacterial load was found 
among animals infected with serotype b. Therefore, losing 
the protective capsule would be expected to render H. in-
fluenzae unable to cause invasive disease. However, recent 
whole genome sequencing results showed that a few in-
vasive NTHi isolates had a multilocus sequence type usu-
ally associated with serotype b strains (32). In these NTHi 
isolates, lack of capsule expression was related to the dele-
tion of the bexA gene, whereas the remaining capsule locus 
was similar to that of the corresponding capsulated isolates. 
However, the lack of a capsule did not abrogate the ability 
of these particular NTHi strains to cause invasive disease, 
indicating that other factors besides the capsule of Hib 
strains contribute to invasiveness. For example, Fleury et 
al. found that a Hib- and Hif-specific lipoprotein PH was 
able to bind human factor H, resulting in increased resis-
tance to complement-mediated killing (33). Identification 
of other genetic factors might partly explain why NTHi is 
found to cause invasive disease.
4) Demographic Changes
The epidemiology of invasive H. influenzae disease has 
changed dramatically over the past 20 years (2,7). Instead 
of being mainly a pediatric disease caused by Hib, former-
ly rare capsular serotypes (mostly Hia and Hif) and NTHi 
cause most of invasive H. influenzae cases, especially 
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Figure 2. Number of recorded non–serotype b capsulated 
Haemophilus influenzae (Hi) isolates from blood or cerebrospinal 
fluid in the Netherlands, by year, 1992–2013. Adapted from (6).
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among the elderly (Table). For instance, in the United 
States, 78% of invasive H. influenzae cases among adults 
>65 years of age were attributed to NTHi, with an even 
higher frequency (89%) among those >85 years of age (34).
Reasons for this apparent increase in susceptibility to 
invasive NTHi infections in the elderly are unknown, but 
the immunologic status of the host is believed to play a 
role. Coexisting conditions or risk factors such as coronary 
artery disease, congestive heart failure, and smoking were 
more common in patients with invasive disease compared 
with the general population (34). The number of patients 
with COPD, the third leading cause of death worldwide 
(35), is increasing. NTHi is often found colonizing the 
lungs of patients with COPD, and the increased number 
of patients with COPD might contribute to the increased 
incidence of invasive NTHi cases. Serum IgG levels to H. 
influenzae protein D showed a tendency to decline with age 
but were even lower in adults with coexisting conditions 
such as COPD, cancer, chronic renal failure, or diabetes, 
compared with age-matched healthy persons (36). The ab-
sence of naturally acquired antibodies against protein D, 
a highly conserved antigen, may contribute to increased 
susceptibility to invasive NTHi disease. However, invasive 
NTHi infections are found not only in persons with immu-
nocompromising conditions (e.g., chronic lymphatic leu-
kemia or multiple myeloma) or coexisting conditions (e.g., 
COPD, diabetes, or cardiovascular diseases) but in almost 
half of cases in persons who were otherwise in good health 
(online Technical Appendix references 6,11).
Recently, several groups have found that binding of 
IgM to the bacterial surface might play a role in the innate 
defense against NTHi infections (25,29,37). This finding 
is corroborated by a clinical study in which Micol et al. 
showed that patients with hyper-IgM syndrome were less 
susceptible to NTHi colonization, a finding that empha-
sizes the role of IgM in the immune defense against this 
pathogen (38). The percentages of IgM-producing CD27+ 
memory B cells in the peripheral blood of children are low 
but increases to almost 20% in adults and declines again in 
the elderly (39). These findings correspond with levels of 
susceptibility to bacterial infections such as NTHi in young 
children and the elderly. Studies examining serum immu-
noglobulin levels in patients with invasive NTHi disease 
compared with those of healthy age-matched patients could 
help address the question of whether a diminished protec-
tive immunoglobulin level in the elderly contributes to sus-
ceptibility to invasive NTHi disease.
Besides impaired humoral immunity, diminished cel-
lular immunity has been described in the elderly. Evidence 
exists for a broad, age-related alteration in the development 
and function of lymphocytes, monocytes, macrophages, and 
neutrophils (40), although specific effects of these changes 
on susceptibility to invasive NTHi infections have not been 
investigated in detail. Recently, we showed that neutrophils 
efficiently phagocytose and kill opsonized NTHi bacteria 
(29), but decreased neutrophil phagocytic capacity among 
the elderly may impair this host defense and contribute to 
poorer clinical outcomes during NTHi infection.
Conclusions
From examination of the available literature, we conclude 
that invasive NTHi disease is emerging worldwide and de-
mands implementation of effective prevention. Develop-
ment of vaccines against NTHi is considered paramount 
because this pathogen is also often found to cause pneumo-
nia in patients with COPD and OM in children. However, 
development of an effective vaccine for risk groups demands 
knowledge about factors that contribute to the emergence of 
invasive NTHi disease. Age and coexisting conditions are 
likely predisposing factors for invasive NTHi infections. 
Also, increased NTHi colonization in children might con-
tribute to increased transmission to persons susceptible to 
developing invasive NTHi disease. In view of these factors, 
broad vaccination strategies for the general public could be 
effective by decreasing transmission, bolstering herd immu-
nity, and protecting potentially susceptible persons.
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